Senolytic drugs prolong survival in mice infected with Mycobacterium tuberculosis when used adjunctively with anti-tuberculosis therapy
Current assessment
Synthesis pending
Confidence
Not assessed
Supporting evidence (0)
Nothing recorded on this side
Contradicting evidence (0)
Nothing recorded on this side
Discussion (0)
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.